Despite strong third-quarter revenues, BioNTech has softened its 2024 sales guidance in light of changes to Covid-19 vaccine uptake, pricing and seasonal variations.
The company …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A once-monthly injectable weight management agent safely induced durable weight loss in a phase I human trial. At the highest dose tested, patients with overweight
Direct oral anticoagulants (DOACs) are a common treatment for patients with a wide variety of cardiovascular conditions.
Health experts are redefining cardiovascular disease (CVD) risk, prevention and management, according to a new American Heart Association presidential advisory published today in the Association’s